TLSITriSalus Life Sciences, Inc.

$175M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M

Gross Profit

$3M87.4% margin

Operating Income

-$9M-301.1% margin

Net Income

-$9M-301.6% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+21.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$70,000

Balance Sheet

Total Assets

$251M

Total Liabilities

$12M

Stockholders' Equity

$239M

Cash & Equivalents

$69,182

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$3M	$0	—
Operating Income	-$9M	-$783,925	-1005.3%
Net Income	-$9M	$378,866	-2390.8%

TLSI Q2 2022 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena